New hope for breast cancer survivors: laser and gel may ease vaginal pain without hormones
NCT ID NCT05585476
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 26 times
Summary
This study tests whether a CO2 laser combined with a regenerative gel can safely relieve vaginal atrophy symptoms—like dryness, pain, and itching—in 180 breast cancer survivors who cannot use hormone therapy. Participants will be randomly assigned to receive the laser plus gel or another treatment. The goal is to improve quality of life and reduce discomfort without hormones.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CO2 microablative laser and regenerative topical gel
What this could lead to
If it works, this could offer a safe, non-hormonal option to relieve painful vaginal symptoms and improve quality of life for breast cancer survivors.
What could go wrong
This is an early-stage trial with no phase assigned, so results are uncertain. The laser and gel may not provide lasting relief, and biopsies are involved.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.